0,958  0,002  CYP2C19 substrate
0,947  0,003  CYP2C9 substrate
0,923  0,004  CYP1A2 substrate
0,916  0,004  Chemoprotective
0,850  0,007  CYP3A4 substrate
0,800  0,006  Radioprotector
0,794  0,012  Caspase 9 stimulant
0,776  0,004  Psychostimulant
0,781  0,018  Antiinflammatory
0,750  0,012  Teratogen
0,725  0,005  Antiosteoporotic
0,724  0,006  Bone diseases treatment
0,734  0,017  Transcription factor NF kappa B inhibitor
0,701  0,004  Myocardial infarction treatment
0,708  0,014  Embryotoxic
0,687  0,002  TRPA1 agonist
0,659  0,009  CTGF expression inhibitor
0,645  0,002  Cannabinoid CB2 receptor antagonist
0,673  0,035  Apoptosis agonist
0,636  0,004  P-glycoprotein inhibitor
0,625  0,011  UGT1A9 substrate
0,601  0,025  TNF expression inhibitor
0,595  0,019  Cholesterol antagonist
0,578  0,008  Antiglaucomic
0,581  0,018  Carcinogenic
0,575  0,015  Chemopreventive
0,572  0,013  Antioxidant
0,563  0,005  Melanin inhibitor
0,572  0,016  Spasmolytic
0,562  0,018  Immunosuppressant
0,555  0,013  Antineoplastic (brain cancer)
0,546  0,005  Muscle relaxant
0,540  0,008  Sedative
0,540  0,007  Antianorexic
0,546  0,015  NOS3 expression inhibitor
0,561  0,031  Alzheimer's disease treatment
0,543  0,014  NOS2 expression inhibitor
0,532  0,004  Neurotrophic factor enhancer
0,542  0,015  CYP2C19 inhibitor
0,545  0,023  Respiratory analeptic
0,528  0,033  Antibacterial
0,505  0,022  Sensitization
0,495  0,021  AR expression inhibitor
0,489  0,024  Analeptic
0,464  0,018  Antiparasitic
0,499  0,054  Antineoplastic (breast cancer)
0,478  0,040  Antipruritic, allergic
0,452  0,023  Proliferative diseases treatment
0,456  0,030  Immunomodulator
0,429  0,004  Neurotrophic factor
0,449  0,027  Antineoplastic (glioma)
0,466  0,045  Antiobesity
0,448  0,031  Cytotoxic
0,449  0,032  Antifungal
0,426  0,014  Antihelmintic
0,439  0,032  Caspase 3 stimulant
0,442  0,035  Antihypercholesterolemic
0,441  0,036  Antineoplastic (ovarian cancer)
0,427  0,023  Antipyretic
0,427  0,025  UGT2B4 substrate
0,434  0,034  Hepatic disorders treatment
0,407  0,011  Antihypotensive
0,434  0,044  Ulceration
0,453  0,064  Analgesic
0,390  0,009  Protein kinase stimulant
0,401  0,025  Nitric oxide antagonist
0,397  0,025  UGT1A6 substrate
0,397  0,031  Hypoxia-inducible factor 1 alpha inhibitor
0,369  0,004  Cannabinoid receptor antagonist
0,365  0,006  Cholesterol synthesis inhibitor
0,419  0,061  Antineoplastic (lung cancer)
0,415  0,059  Antileukemic
0,377  0,021  Eye irritation, high
0,378  0,025  Sodium/bile acid cotransporter inhibitor
0,365  0,012  Lipid peroxidase inhibitor
0,402  0,049  Immunostimulant
0,384  0,032  Mutagenic
0,370  0,019  UGT1A4 substrate
0,373  0,027  Angiogenesis stimulant
0,385  0,040  Vasodilator, coronary
0,385  0,042  Cardioprotectant
0,341  0,004  Posttraumatic stress disorder treatment
0,370  0,035  Free radical scavenger
0,358  0,024  Abortion inducer
0,366  0,037  Antiprotozoal (Leishmania)
0,340  0,016  Antipruritic, non-allergic
0,330  0,008  Antifungal enhancer
0,346  0,027  UDP-glucuronosyltransferase substrate
0,365  0,048  Lipoprotein disorders treatment
0,334  0,020  UGT2B7 substrate
0,338  0,025  UGT1A1 substrate
0,350  0,042  Cytostatic
0,362  0,055  Antihypertensive
0,309  0,004  Cannabinoid CB1 receptor antagonist
0,328  0,023  Non-steroidal antiinflammatory agent
0,362  0,062  Prostate cancer treatment
0,308  0,010  DNA polymerase I inhibitor
0,380  0,087  Antiparkinsonian
0,314  0,022  Contraceptive
0,351  0,061  ICAM1 expression inhibitor
0,362  0,075  CYP2C9 inhibitor
0,336  0,056  Antineoplastic (pancreatic cancer)
0,283  0,005  Estrogen receptor alpha antagonist
0,304  0,028  Hepatoprotectant
0,292  0,020  Protein-tyrosine phosphatase inhibitor
0,329  0,059  Metabolic disease treatment
0,290  0,022  Acaricide
0,272  0,004  Actinic keratosis treatment
0,285  0,019  Monophenol monooxygenase inhibitor
0,309  0,048  Antineoplastic (liver cancer)
0,328  0,067  Apoptosis antagonist
0,279  0,022  Skin whitener
0,258  0,002  Anabolic
0,263  0,008  SULT1A1 substrate
0,269  0,016  UGT2B9 substrate
0,298  0,046  5 Hydroxytryptamine uptake stimulant
0,355  0,111  5 Hydroxytryptamine release inhibitor
0,253  0,013  VEGF expression inhibitor
0,307  0,068  Lipoxygenase inhibitor
0,292  0,053  GST M1-1 substrate
0,266  0,027  Antiseptic
0,298  0,062  Antineurogenic pain
0,261  0,026  Hair growth stimulant
0,317  0,088  Vasodilator, peripheral
0,255  0,026  UGT2B15 substrate
0,245  0,017  SULT1A3 substrate
0,326  0,097  GST A substrate
0,349  0,123  Antidiabetic
0,349  0,123  Cyclophilin D inhibitor
0,280  0,055  Vasodilator
0,295  0,072  Antineoplastic (melanoma)
0,280  0,061  Antineoplastic (renal cancer)
0,272  0,055  Antineoplastic (glioblastoma multiforme)
0,274  0,058  Hypolipemic
0,273  0,064  Hypoglycemic
0,227  0,021  UGT2B10 substrate
0,213  0,007  Prolactin inhibitor
0,220  0,014  Antiemetic
0,245  0,040  Diabetic retinopathy treatment
0,226  0,022  Protein-tyrosine phosphatase 1B inhibitor
0,207  0,005  Cannabinoid CB1 receptor agonist
0,211  0,009  Adenylate cyclase stimulant
0,240  0,041  Antimutagenic
0,290  0,095  Antithrombotic
0,211  0,023  Alkylator
0,259  0,071  Antineoplastic (cervical cancer)
0,195  0,009  Thioredoxin inhibitor
0,219  0,035  Skeletal muscle relaxant
0,188  0,005  Ornithine decarboxylase inhibitor
0,196  0,013  Vanilloid 1 agonist
0,224  0,043  Lipocortins synthesis antagonist
0,234  0,056  Wound healing agent
0,199  0,021  Retinoprotector
0,227  0,050  Growth hormone agonist
0,183  0,008  Vanilloid agonist
0,185  0,010  Electron transport complex I inhibitor
0,283  0,110  Calcium channel activator
0,188  0,018  UGT2B1 substrate
0,265  0,095  Antipsoriatic
0,191  0,023  Antineoplastic antibiotic
0,205  0,039  Interferon gamma antagonist
0,199  0,034  Arachidonic acid antagonist
0,241  0,077  Antineoplastic (sarcoma)
0,241  0,078  Cardiovascular analeptic
0,209  0,046  UGT1A3 substrate
0,200  0,040  Interleukin 6 antagonist
0,259  0,101  CYP2D6 substrate
0,173  0,019  Aldehyde dehydrogenase substrate
0,233  0,080  Platelet antagonist
0,172  0,021  Contraceptive female
0,177  0,031  Farnesoid X receptor antagonist
0,192  0,046  Antineoplastic (bone cancer)
0,238  0,095  5 Hydroxytryptamine release stimulant
0,255  0,113  Interleukin 2 agonist
0,209  0,069  Anesthetic general
0,229  0,089  Vascular (periferal) disease treatment
0,161  0,023  Ca2+-transporting ATPase inhibitor
0,182  0,044  Genotoxic
0,237  0,099  CYP1A2 inhibitor
0,184  0,047  Antiacne
0,148  0,011  Antiprotozoal activity enhancer
0,217  0,082  Antineoplastic (lymphoma)
0,214  0,081  RNA-directed DNA polymerase inhibitor
0,159  0,028  Alcohol dehydrogenase substrate
0,184  0,053  ATPase inhibitor
0,248  0,119  Antineoplastic (osteosarcoma)
0,146  0,017  UGT2B11 substrate
0,259  0,130  Antiprotozoal (Plasmodium)
0,167  0,038  Antihyperlipoproteinemic
0,165  0,038  Interleukin 4 antagonist
0,141  0,015  Tourette's syndrome treatment
0,147  0,024  Estrogen antagonist
0,132  0,010  SULT1A2 substrate
0,183  0,062  Antirickettsial
0,149  0,028  Sulfotransferase substrate
0,268  0,148  Antiprotozoal
0,173  0,054  NOS3 expression enhancer
0,178  0,063  Phospholipase C inhibitor
0,157  0,041  Antihemorrhagic
0,155  0,045  Skin irritative effect
0,161  0,052  Movement disorders treatment
0,142  0,034  Bronchodilator
0,125  0,018  CDC25A inhibitor
0,212  0,105  DNA synthesis inhibitor
0,278  0,171  Antiarthritic
0,197  0,090  Antiulcerative
0,194  0,087  Antihypertriglyceridemic
0,170  0,066  Prostate disorders treatment
0,222  0,118  Antiepileptic
0,155  0,052  Cachexia treatment
0,183  0,082  Growth factor agonist
0,118  0,017  Na+ K+ transporting ATPase inhibitor
0,127  0,026  Paget's disease treatment
0,144  0,046  Growth stimulant
0,244  0,147  Stroke treatment
0,118  0,021  Bile acid receptor antagonist
0,116  0,020  Cannabinoid receptor agonist
0,158  0,063  Antidiarrheal
0,125  0,031  Androgen antagonist
0,250  0,155  Histamine release inhibitor
0,110  0,016  Glycine receptor agonist
0,162  0,069  Antiviral (Herpes)
0,199  0,108  Antidiabetic symptomatic
0,137  0,047  Cystathionine beta-synthase inhibitor
0,135  0,047  Microtubule formation inhibitor
0,161  0,072  Uterine stimulant
0,120  0,032  Estrogen receptor beta antagonist
0,107  0,020  Aromatase inhibitor
0,180  0,096  Pneumotoxic
0,210  0,127  Antineoplastic (colorectal cancer)
0,144  0,064  Bone formation stimulant
0,109  0,029  ATPase (Vacuolar H+) inhibitor
0,133  0,054  Papain-like protease (SARS coronavirus) inhibitor
0,199  0,120  Cardiotonic
0,092  0,014  Glutamate (mGluR6) antagonist
0,200  0,123  Antineoplastic (colon cancer)
0,142  0,066  Anesthetic
0,144  0,068  Antifungal (Cryptococcus)
0,205  0,130  Antidiabetic (type 2)
0,110  0,035  Phosphodiesterase 6D inhibitor
0,087  0,015  Hypercalcemia treatment
0,101  0,030  Keratolytic
0,227  0,156  FMO1 substrate
0,130  0,060  Coagulant
0,154  0,090  Dual specificity phosphatase inhibitor
0,101  0,038  Transcription factor NF kappa B stimulant
0,064  0,002  Vanilloid 2 agonist
0,114  0,055  Expectorant
0,118  0,060  Photosensitizer
0,200  0,142  Antiischemic
0,068  0,011  Dopamine D3 agonist
0,070  0,014  Vanilloid 2 antagonist
0,155  0,100  Platelet adhesion inhibitor
0,113  0,059  Choleretic
0,071  0,017  Acetyl-CoA transferase 2 inhibitor
0,102  0,048  ABCA1 expression enhancer
0,062  0,010  Parathyroid hormone antagonist
0,232  0,180  15-Lipoxygenase inhibitor
0,137  0,085  Antiviral (Influenza A)
0,155  0,104  LDLR expression enhancer
0,119  0,068  Topoisomerase II inhibitor
0,072  0,022  Sphingosine kinase inhibitor
0,099  0,050  SULT1E1 substrate
0,081  0,032  Anticholelithogenic
0,070  0,024  Protein 50S ribosomal subunit inhibitor
0,050  0,004  Toll-Like receptor 4 agonist
0,087  0,042  Interferon agonist
0,157  0,113  Cardiodepressant
0,071  0,029  Cannabinoid CB2 receptor agonist
0,105  0,063  Antihypermotility
0,071  0,030  Androgen agonist
0,087  0,047  Glycine receptor antagonist
0,071  0,032  TRPA1 antagonist
0,072  0,032  Interferon inducer
0,170  0,132  VCAM1 expression inhibitor
0,194  0,157  Antineoplastic (multiple myeloma)
0,080  0,043  Lipase inhibitor
0,262  0,225  Antineoplastic (solid tumors)
0,064  0,028  Postcoital contraceptive
0,150  0,114  Toxic, respiratory center
0,081  0,046  Antibiotic
0,137  0,102  CF transmembrane conductance regulator agonist
0,051  0,019  Estrogen receptor beta agonist
0,134  0,106  Antihelmintic (Nematodes)
0,059  0,031  Estrogen agonist
0,129  0,103  Pregnane X receptor agonist
0,133  0,108  Heat shock protein 70 antagonist
0,060  0,036  Lipocortins synthesis agonist
0,218  0,194  Antineoplastic (endocrine cancer)
0,042  0,020  Retinoid X receptor antagonist
0,030  0,007  Vitamin D receptor antagonist
0,152  0,131  CYP2B6 inhibitor
0,036  0,016  ATP citrate lysase inhibitor
0,067  0,047  Dopamine agonist
0,062  0,043  Antimycoplasmal
0,064  0,046  Leukotriene antagonist
0,075  0,056  Antitreponemal
0,110  0,092  Antiviral (Influenza B)
0,131  0,114  Liver fibrosis treatment
0,080  0,065  Antiviral (Dengue virus)
0,056  0,042  Pregnane X receptor antagonist
0,036  0,023  Estrogen receptor alpha agonist
0,025  0,012  Prostaglandin F2 alpha agonist
0,088  0,075  Xanthine oxidase inhibitor
0,028  0,016  Hedgehog signaling activator
0,164  0,154  Interleukin agonist
0,078  0,068  Antineoplastic alkaloid
0,190  0,183  FMO3 substrate
0,017  0,010  Prostacyclin agonist
0,050  0,044  Leukotriene B4 antagonist
0,152  0,146  Antialcoholic
0,087  0,081  Chronic obstructive bronchitis treatment
0,043  0,038  Microtubule stabilization
0,065  0,061  SULT2A1 substrate
0,061  0,057  Peroxisome proliferator-activated receptor gamma agonist
0,033  0,029  Calcium-independent phospholipase A2 inhibitor
0,144  0,141  Insulin sensitizer
0,021  0,018  CYP24 inhibitor
0,152  0,150  Antiviral (HIV)
0,024  0,022  Sodium/glucose cotransporter 2 inhibitor
0,090  0,089  Toll-Like receptor 4 antagonist
0,031  0,030  Retinoid X alpha receptor antagonist
0,027  0,027  Prostaglandin agonist
0,009  0,009  Thromboxane agonist

